"Febuxostat" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.
Descriptor ID |
D000069465
|
MeSH Number(s) |
D02.886.675.274 D03.383.129.708.274
|
Concept/Terms |
TEI 6720- TEI 6720
- 6720, TEI
- TEI-6720
- TEI6720
|
Below are MeSH descriptors whose meaning is more general than "Febuxostat".
Below are MeSH descriptors whose meaning is more specific than "Febuxostat".
This graph shows the total number of publications written about "Febuxostat" by people in this website by year, and whether "Febuxostat" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Febuxostat" by people in Profiles.
-
Kaul S, Gupta M, Bandyopadhyay D, Hajra A, Deedwania P, Roddy E, Mamas M, Klein A, Lavie CJ, Fonarow GC, Ghosh RK. Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes. Am J Cardiovasc Drugs. 2021 Sep; 21(5):499-512.
-
Jutkowitz E, Alarid-Escudero F, Choi HK, Kuntz KM, Jalal H. Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis. Pharmacoeconomics. 2017 Oct; 35(10):1073-1085.